Analysis of blood component transfusion and some adverse reactions in myelodysplastic syndroms patients

Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 8

Abstract

Objective To analyze the blood transfusion and adverse reactions in myelodysplastic syndroms (MDS) patients, so as to improve transfusion management in MDS patients. Methods The diagnosis and treatment information of MDS patients with blood transfusion in our hospital from January 2003 to December 2022 were collected, and the component transfusion and adverse reactions were investigated. Results The average infusion volume of red blood cells(RBCs) and platelets were respectively (27.46±43.11 ) and (16.41±24.81 ) in 799 MDS patients, which had no correlation with gender and blood type. The incidence of adverse reactions was 18.27% (146/799), with the most common adverse reactions as delayed serologic transfusion reaction (DSTR) (9.01%, 72/799), followed by non hemolytic fever reaction (4.76%, 38/799) and allergic reaction (4.38%, 35/799). Compared with all patients with transfusion, DSTR was more common in females (P<0.05), with elder age and had more RBCs consumption (all P<0.01). 86.11%(62/72) were Rh system, and 40.28% (29/72) had 2 or more antibodies. The occurrence time of DSTR in some patients was not related to the volume of RBCs trans infusion. Conclusion MDS patients, with more average transfusion volume and higher incidence of adverse reactions especially DSTR, were recommended a strictly limited transfusion schedule and Rh phenotype matching RBC products. The investigation of immune status of MDS patients at different periods is helpful to provide new aspects and therapeutic measures for the pathogenesis of DSTR, and the antibody screening time may adjusted appropriately.

Authors and Affiliations

Wenhao XU, Youshan ZHAO, Chao XIAO, Chunkang CHANG

Keywords

Related Articles

Systemic lupus erythematosus induced thrombotic thrombocytopenic purpura treated with plasma exchange combined with high-dose steroid pulse therapy: a case report

Objective To analyze the clinical outcomes of a patient with thrombotic thrombocytopenic purpura(TTP) as the starting performance who was considered as systemic lupus erythematosus(SLE) under multiple abnormal autoantibo...

Model of "One Core, Multiple Elements" emergency blood donation volunteer team: a case study of Nanjing city

Objective To explore the model of "One Core, Multiple Elements" emergency blood donation volunteer team (referred to as the Model) . Methods The Nanjing City Voluntary Blood Donation Joint Meeting serves as the core, wit...

Addressing blood safety implications of donors using HIV antiretroviral therapy

HIV infection and transmission is a serious threat to people's health and public health security. Antiretroviral therapy (ART), including pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), has played a...

Platelet-rich plasma combined with gypenosides for the treatment of psoriasis-like inflammation in mice

[Objective] To investigate the therapeutic effect of platelet-rich plasma (PRP) subcutaneous injection combined with gypenosides (GPs) oral administration on BALB/c mouse psoriatic inflammation and explore its mechanism...

Study on the changes of extracellular vesicle content of platelets at different storage periods, storage lesion and clinical efficacy

[Objective] To analyze the changes of platelet extracellular vesicles (PEVs) content in apheresis at different storage periods, track the PEVs and transfusion efficacy of patients, and explore the mechanism of PEVs in re...

Download PDF file
  • EP ID EP738611
  • DOI 10.13303/j.cjbt.issn.1004-549x.2023.08.008
  • Views 45
  • Downloads 0

How To Cite

Wenhao XU, Youshan ZHAO, Chao XIAO, Chunkang CHANG (2023). Analysis of blood component transfusion and some adverse reactions in myelodysplastic syndroms patients. Chinese Journal of Blood Transfusion, 36(8), -. https://europub.co.uk./articles/-A-738611